Prospective Cohort Study of the Relative Abundance of Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli in the Gut of Patients Admitted to Hospitals

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6941-6944. doi: 10.1128/AAC.01328-16. Print 2016 Nov.

Abstract

A total of 458 patients were prospectively included at hospital admission and screened for extended-spectrum-beta-lactamase-producing (ESBL) Escherichia coli carriage in 2007 and in 2010 to 2012. A 4-fold increase in ESBL carriage (3% to 12%), a 5-fold increase in numbers of community patients among ESBL carriers, and a higher number of multiple ESBL strains was found in the 2010 to 2012 period. ESBL E. coli represented the dominant E. coli strain (relative abundance, >50%) in 10/32 (31%) of ESBL carriers. This represents a major threat in terms of infectious risk and dissemination.

MeSH terms

  • Aged
  • Bacterial Load
  • Carrier State
  • Escherichia coli / genetics*
  • Escherichia coli / isolation & purification*
  • Female
  • France
  • Gastrointestinal Microbiome*
  • Hospitals
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • beta-Lactamases / genetics*

Substances

  • beta-lactamase CTX-M-15
  • beta-Lactamases

Grants and funding

This work was funded by the IAME Research Group, UMR1137 INSERM, and University Paris Diderot.